Skip to content

Penicillin Allergy in Shfayim Clinic

Penicillin Allergy in Shfayim Clinic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03499457
Enrollment
100
Registered
2018-04-17
Start date
2018-06-30
Completion date
2019-06-30
Last updated
2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penicillin Allergy

Keywords

Penicillin Allergy, chalenge test, primary clinic

Brief summary

revising penicillin allergy in the medical records, by taking full medical history and giving a challange test, in order to imrove the medical records and treatment possibilities.

Detailed description

issuing a list of patients with a title of penicillin allergy in their medical record. inviting these patients to an appointmnet with their family physician, in which a specific history will be take to evaluate the quality of the allergy. patients with suscpition of a life threatening allergic reaction will be reffered to an allergy clinic for the challange test. the rest of the pateints will be given the test in the primary clinic: 1ml (50 grams) of amoxicillin, and an hour later a full dose of 500 mg amoxicillin. after determining no allergic reaction develops the title will be erased from the medical record.

Interventions

DRUGAmoxicillin

chalange test of 50 mg, and after an hour 500 mg

Sponsors

Clalit Health Services
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

penicillin allergy in the medical record

Exclusion criteria

pregnancy lack of informed consent

Design outcomes

Primary

MeasureTime frameDescription
immidiate urticarial reactionwith 2 hours of testshortness of breath, angioedema

Secondary

MeasureTime frameDescription
rashwith 2 hours of testbody rash or itch seen by patient or physician

Contacts

Primary Contactlital f goldberg, MD. MPH.
litalmargalith@gmail.com972544248284

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026